Clinical Trial: Study of Telaprevir in Subjects With Hepatic Impairment
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title:
Brief Summary: The purpose of this study is to assess the safety and pharmacokinetics of Telaprevir following administration of multiple oral doses to subjects with moderate and severe hepatic impairment.
Detailed Summary:
Sponsor: Vertex Pharmaceuticals Incorporated
Current Primary Outcome: Pharmacokinetics
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Vertex Pharmaceuticals Incorporated
Dates:
Date Received: July 30, 2007
Date Started: September 2007
Date Completion:
Last Updated: October 28, 2008
Last Verified: October 2008